Mydx Inc (OTCMKTS:MYDX), a science and technology based company and producer of MyDx® (My Diagnostic) recently announced successfully and amicably resolving the misunderstanding with its  toxic convertible debenture lenders. MyDx®  is the...

MyDx Inc (OTCMKTS:MYDX) has announced that the issue between the firm and its convertible debenture lenders has been resolved. The MyDx creator and science and technology firm had earlier in the month filed a restraining order after continuing...

Cannabis Science Inc (OTCMKTS:CBIS) a U.S. firm specializing in the advancement of cannabis-based medicines, released updates on the planned self-administering DPI Inhalation Device for COPD/ Asthma and their CBD infused pain patch. The firm...

Acology Inc (OTCMKTS:ACOL) posted that earnings had surged 12.5% throughout the last quarter of FY2016, despite notable expenses in expansion, infrastructure and additional manpower costs. Executives are estimating that the net-impact of investments...

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) through its Israeli based subsidiary named One world Cannabis Ltd released yearly letter to update company’s shareholders on overall performance. The firm also shares its objectives and goals...

Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) closed up over 22% on Wednesday at $2.02 trading around 4 million shares by the market close. The company recently reported that it will commence offering personalized CBD anti-tumor tests for people...